ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,414,970, issued on Sept. 16, was assigned to My Health International (Diepenbeek, Belgium).

"Bacillus coagulans and Bacillus subtilis for the prevention and treatment of functional gastro-intestinal disorders" was invented by Raf Dybajlo (Lummen, Belgium), Wannes Thys (Bilzen, Belgium), Lucas Wauters (Leuven, Belgium) and Tim Vanuytsel (Leuven, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention in general relates to the use of probiotics for the management of functional gastrointestinal disorders. More specifically, the present invention relates to the use of Bacillus coagulans or Bacillus subtilis or a combination of both strains for...